Correct Answer: D. Immediate pelvic examination, Pap smear, and transvaginal ultrasound
Postmenopausal bleeding (PMB) is always pathological until proven otherwise—this is the cardinal rule in gynecology. The presence of vaginal bleeding in any postmenopausal woman mandates immediate evaluation regardless of age, comorbidities, or blood pressure status. The most common etiologies are endometrial cancer (10–15% of PMB cases), endometrial polyps, endometrial hyperplasia, and atrophic vaginitis. Elevated blood pressure is a separate clinical issue and does not take precedence over investigating PMB. The standard diagnostic approach includes: (1) detailed history and pelvic examination to rule out lower genital tract pathology (cervical lesions, vaginal atrophy, bleeding sources), (2) Pap smear to screen for cervical malignancy, and (3) transvaginal ultrasound (TVS) to assess endometrial thickness and morphology. TVS is the first-line imaging modality in India and internationally because it has superior resolution for endometrial pathology compared to transabdominal ultrasound. An endometrial thickness >4 mm in a postmenopausal woman warrants further evaluation (endometrial biopsy or hysteroscopy). Delaying this evaluation or attributing PMB to hypertension or age is a common clinical error that can result in delayed diagnosis of endometrial malignancy. Per Indian guidelines (FOGSI, ICOG) and Harrison, PMB evaluation must be initiated immediately.
Why the other options are wrong
A. Reassure her that this is normal at her age — This is a dangerous misconception. Postmenopausal bleeding is NEVER normal and is pathological until proven otherwise. Reassurance without evaluation delays diagnosis of endometrial cancer, which accounts for 10–15% of PMB cases. Age alone does not make PMB acceptable; in fact, older postmenopausal women are at higher risk for malignancy. This option represents a critical diagnostic error. B. Refer her to cardiology before any further evaluation — While hypertension (170/100 mmHg) requires management, it is not the presenting complaint requiring urgent attention. Cardiology referral for hypertension control should not delay gynecological evaluation of PMB. The two conditions are independent; PMB evaluation takes priority because of the risk of occult malignancy. This option inappropriately deprioritizes a potentially serious gynecological condition. C. Start antihypertensives and observe for 1 week — Observing PMB for a week is inappropriate and dangerous. Delaying evaluation of postmenopausal bleeding increases the risk of missing early-stage endometrial cancer. While antihypertensive therapy is eventually needed, it should not delay gynecological assessment. This option conflates two separate clinical problems and prioritizes the wrong one, risking delayed cancer diagnosis.
High-Yield Facts
- Postmenopausal bleeding is pathological until proven otherwise—immediate evaluation is mandatory regardless of age or comorbidities.
- Endometrial cancer accounts for 10–15% of postmenopausal bleeding cases—early detection significantly improves prognosis.
- Transvaginal ultrasound is the first-line imaging modality for PMB evaluation; endometrial thickness >4 mm warrants further investigation.
- Pap smear screens for cervical malignancy and is part of the standard PMB workup to exclude cervical sources of bleeding.
- Pelvic examination is essential to identify lower genital tract pathology (cervical lesions, vaginal atrophy, polyps) before imaging.
Mnemonics
PMB = Pathological until proven otherwise Any postmenopausal bleeding demands immediate evaluation. Never reassure or delay. Think: Cancer until proven benign. EXAM-US for PMB E = Examine (pelvic exam), X = eXclude cervical pathology (Pap smear), A = Assess endometrium (TVS), M = Measure thickness (>4 mm = biopsy), U = Ultrasound first, S = Send for histology if needed.
NBE Trap
NBE may pair hypertension with postmenopausal bleeding to distract candidates into prioritizing blood pressure management or cardiology referral, when the discriminating feature is that PMB is always pathological and requires immediate gynecological evaluation regardless of concurrent medical conditions.
Clinical Pearl
In Indian clinical practice, many postmenopausal women with hypertension present to general practitioners or cardiologists first. The critical teaching point is that PMB must never be attributed to age or deferred for other comorbidities—it is the gynecologist's responsibility to evaluate immediately, and the referring physician must not delay this evaluation. Early detection of endometrial cancer in India, where screening programs are limited, depends entirely on this principle.
_Reference: Harrison Ch. 50 (Menopause); DC Dutta's Textbook of Gynaecology Ch. 12 (Abnormal Uterine Bleeding); FOGSI Guidelines on Postmenopausal Bleeding_